Immune mechanisms in neurodegenerative disorders

Drugs of Today

Volumn 32, Issue 2, 1996, Pages 149-158

  McGeer, Patrick L ^a   McGeer, Edith G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ARTHRITIS; ECONOMICS; HISTOCHEMISTRY; HUMAN; INFLAMMATION; NERVE CELL DEGENERATION; REVIEW;

EID: 0029875437     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. McGeer, P.L., McGeer, E.G. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res, in press.
2. McGeer, E.G., McGeer, P.L. Neurodegeneration and the immune system. In: Neurodegenerative Disorders. Calne, D.B. (Ed.). WB Saunders: Philadelphia 1994, 277-300.
3. McGeer, P.L., Rogers, J., McGeer, E.G. Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alz Dis Assoc Disord 1994, 8: 149-65.
4. McGeer, P.L., Rogers, J. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992, 42: 447-9.
5. Ohm, T.G., Müller, H., Braak, H., Bohl, J. Closemeshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes. Neuroscience 1995, 64: 209-17.
6. Helmes, E., Merskey, H., Fox, H. et al. Patterns of deterioration in senile dementia of the Alzheimer type. Arch Neurol 1995, 52: 306-10.
7. Rother, K., Till, G.O. (Eds.). The Complement System. Springer-Verlag: Berlin, Heidelberg 1988.
8. Eikelenboom, P., Hack, C.E., Rozemuller, J.M., Stam, F.C. Complement activation in amyloid plaques in Alzheimer's dementia. Virch Arch B Cell Pathol 1989, 56: 259-62.
9. Ishii, T., Haga, S. Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques. Acta Neuropathol 1984, 63: 296-300.
10. McGeer, P.L., Akiyama, H., Itagaki, S., McGeer, E.G. Immune system response in Alzheimer's disease. Can J Neurol Sci 1989, 16: 516-27.
11. Akiyama, H., McGeer, P.L. Brain microglia constitutively express β2 integrins. J Neuroimmunol 1990, 30: 81-93.
12. Rozemuller, J.M., Eikelenboom, P., Pals, S.T., Stam, F.C. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 1989, 101: 288-92.
13. Yasuhara, O., Aimi, Y., McGeer, E.G., McGeer, P.L. Expression of the complement membrane attack complex and its inhibitors in Pick disease brain. Brain Res 1994, 652: 346-9.
14. Bellavite, P. The superoxide-forming enzymatic system of phagocytes. Free Radical Biol Med 1988, 4: 225-61.
15. Akiyama, H., Tooyama, I., Kondo, H. et al. Early response of brain resident microglia to kainic acid-induced hippocampal lesions. Brain Res 1994, 635: 257-68.
16. Pasinetti, G.M., Johnson, S.A., Rozovsky, I. et al. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp Neurol 1992, 118: 117-25.
17. Rogers, J., Cooper, N.R., Webster, S. et al. Complement activation by β-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992, 89: 10016-20.
18. Jiang, H., Burdick, D., Glabe, G.G., Cotman, C.W., Tenner, A.J. β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 1994, 152: 5050-9.
19. Akiyama, H., Yamada, T., Kawamata, T., McGeer, P.L. Association of amyloid P component with complement proteins in neurologically diseased tissue. Brain Res 1991, 548: 349-52.
20. Duong, T., Pommier, E.G., Schiebel, A.B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989, 78: 429-37.
21. Hicks, P.S., Saunero-Nazia, L., Duclos, T.W., Mold, C. Serum amyloid P component binds to histones and activates the classical complement pathway. J Immunol 1992, 149: 3689-94.
22. Jiang, H, Robey, F.A., Gewurz, H. Localization of sites through which C-reactive protein binds to and activates complement to residues 14-26 and 76-92 of the human C1q A chain. J Exp Med 1992, 175: 1373-9.
23. Yasuhara, O., Walker, D.G., McGeer, P.L. Hageman factor and its binding sites are present in senile plaques of Alzheimer's disease. Brain Res 1994, 654: 234-40.
24. McGeer, P.L., McGeer, E.G., Rogers, J., Sibley, J. Anti-inflammatory drugs and Alzheimer disease. Lancet 1990, 335: 1037.
25. Heyman, A., Wilkinson, W.E., Stafford, J.A., Helms, M.J., Sigmon, A.H., Weinberg, T. Alzheimer's disease: A study of epidemiological aspects. Ann Neurol 1984, 15: 335-41.
26. French, L.R., Schuman, L.M., Mortimer, J.A., Hutton, J.T., Boatman, R.A., Chrimstians, B. A case-control study of dementia of the Alzheimer's type. Amer J Epidemiol 1985, 121: 414-21.
27. Broe, G.A., Henderson, A.S., Creasey, H. et al. A case-control study of Alzheimer's disease in Australia. Neurology 1990, 40: 1698-707.
28. Breteler, M.M.B., van Duijn, C.M., Andra, V.C.I. et al. Medical history and the risk of Alzheimer's disease: A collaborative re-analysis of casecontrol studies. Int J Epidemiol 1991, 20: S36-42.
29. Li, G., Shen, Y.C., Chen, C.H., Zhau, Y.W., Silverman, J.M. A case-control study of Alzheimer's disease in China. Neurology 1992, 42: 1481-2.
30. Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1944, 44: 2073-80.
31. Breitner, J.C.S., Gau, B.A., Welsh, K.A. et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease. Neurology 1994, 44: 227-32.
32. 2 blocking drugs. Neurobiol Aging 1995, 16: 523-30.
33. Graves, A.B., White, E., Koepsell, T.D. et al. A case-control study of Alzheimer's disease. Ann Neurol 1990, 28: 766-74.
34. Jenkinson, M.I., Bliss, M.R., Brain, A.T., Scott, D.L. Rheumatoid arthritis and senile dementia of the Alzheimer's type. Brit J Rheumatol 1989, 28: 86-7.
35. Beard, C.M., Kokmen, E., Kurland, L.T. Rheumatoid arthritis and susceptibility to Alzheimer's disease. Lancet 1991, 337: 1426.
36. Myllykangas-Luosujarvi, R., Isomaki, H. Alzheimer's disease and rheumatoid arthritis. Brit J Rheumatol 1994, 33: 501-2.
37. Lucca, U., Tettamanti, M., Forloni, G., Spagnoli, A. Nonsteroidal antiinflammatory drug use in Alzheimer's disease. Biol Psychiatry 1994, 36: 854-6.
38. Andersen, K., Launer, L.J., Ott, A., Hoes, A.W., Breteler, M.M.B., Hofman, A. Do nonsteroidal antiinflammatory drugs decrease the risk of Alzheimer's disease? Neurology 1995, 45: 51-5.
39. Rich, T.B., Rasmusson, D.X., Folstein, M.F. et al. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease. Neurology 1995, 45: 51-5.
40. McGeer, P.L., Harada, N., Kimura, H., McGeer, E.G., Schuizer. M. Prevalence of dementia amongst elderly Japanese with leprosy: Apparent effect of chronic drug therapy. Dementia 1992, 3: 146-9.
41. Canadian Study of Health and Aging: Study methods and prevalence of dementia. Can Med Assoc J 1994, 150: 899-913.
42. Rogers, J., Kirby, L.C., Hempelman, S.R. et al. Clinical trial of indomethacin in Alzheimer's disease. Neurology 1993, 43: 1609-11.
43. Mortimer, J.A., Ebbitt, B., Jun, S.-P., Finch, M.D. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992, 42. 1689-96.
44. Ostbye, T., Crosse, E. Net economic costs of dementia in Canada. Can Med Assoc J 1994, 151: 1457-64.
45. Perry, D. Biomedical research: Missing in the Medicare action. FASEB Newslett 1995, 10: 2-3.
46. Landfield, P. W., Eldridge, J.C. Increased affinity of type II corticosteroid binding in aged rat hippocampus. Exp Neurol 1989, 106: 110-3.
47. Lewis, D.A., Smith, R.E. Steroid-induced psychiatric syndromes. J Affect Disord 1983, 5: 319-32.
48. Graham, D.Y., Agrawal, N.M., Roth, S.H. Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebocontrolled trial. Lancet 1988, ii: 1277-80.